DEVELOPER TOOLS

454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation (NASDAQ:CRGN), announced today that Katherine Webster has joined the company as Vice President for Measurement Services Center Sales. In this newly created role, Ms. Webster will be responsible for expanding the role of the Measurement Services Center worldwide and growing revenues associated with the sequencing services provided by 454 Life Sciences. "Katherine has extensive knowledge of the biotechnology industry, and her management and sales expertise related to genomics and bioinformatics will be key to helping us aggressively grow our measurement services business," stated Chris McLeod, 454 Life Sciences' CEO. "We are delighted that she has joined our organization as we believe her track record of success will help us achieve our corporate objectives." Most recently, Ms. Webster was President of Biotage, Biosystems Division (formerly Pyrosequencing AB), which she had joined as Vice President, Sales & Marketing. At Biotage, she successfully redirected the company's sales and marketing efforts into the clinical research and diagnostic markets. Ms. Webster's experience also includes positions at Applied Biosystems, Chemdex, Celera Genomics, AnVil Informatics and Molecular Staging. Ms. Webster has a Bachelor of Science degree from SUNY College of Environmental Science and Forestry (Syracuse, New York), and holds a Management Certificate from the University of Cincinnati College of Business Administration.